Drugs / 11-valent Pneumococcal Conjugate Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00169481 | Oct 2004 → May 2005 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 11-valent Pneumococcal Conjugate Vaccine | “GlaxoSmithKline Biologicals' 11-valent Pneumococcal Conjugate Vaccine” NCT00169481 ↗ |
| Modality | Vaccine | “11-valent pneumococcal conjugate vaccine” NCT00169481 ↗ |
| Route | Intramuscular | “administered Intramuscularly” NCT00169481 ↗ |